Quantcast

Latest Piperazines Stories

2014-06-25 23:13:33

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) June 25, 2014 The prescription drug safety center DrugNews.net has added new research information to the site for patients who have taken popular erectile dysfunction drugs like Viagra. After a recent study found men who’d taken the drugs had a higher rate of skin cancer*, doctors are recommending more research**....

2014-06-25 08:32:36

$1.5 million in proceeds to fund 2014 commencement of HPPI's clinical development program for repurposing the approved anti-fungal drug itraconazole for the treatment of cancer, initially for the treatment of Basal Cell Carcinoma Nevus Syndrome TAMPA, Fla. and SAN DIEGO, June 25, 2014 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with...

2014-06-19 12:26:36

LONDON, June 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019...

2014-06-10 23:09:43

For men with erectile problems, taking one of the four medications available can produce an erection 70% of the time. Boston, MA (PRWEB) June 10, 2014 For the estimated half of men between the ages of 40 and 70 who have trouble getting or sustaining an erection, taking a medication can often remedy the problem. With four erectile dysfunction drugs on the market, men have options. But their choices are often limited by cost and health insurance rules, reports the June 2014 Harvard...

2014-06-09 08:29:03

SUNNYVALE, Calif., June 9, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval. The sNDA was submitted to the FDA based on data from the...

2014-06-05 12:28:09

Two New Therapies Will Match Progression-Free Survival Improvements Required By Surveyed U.S. Payers for Formulary Inclusion, According to a New Report from Decision Resources Group BURLINGTON, Mass., June 5, 2014 /PRNewswire/ -- Decision Resources Group finds that in addition to an improvement in median overall survival (MOS), delayed disease progression is one of the greatest unmet needs in the first-line treatment of advanced ovarian cancer (CaO). MOS and disease progression are also key...

2014-06-04 23:13:56

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) June 04, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients who have taken popular erectile dysfunction drugs like Viagra of new information on the site. A recent study found that men taking these medications were nearly twice as likely to develop melanoma skin cancer*. DrugNews is a...

2014-06-04 23:01:50

On June 3, the FDA notified consumers not to purchase or use Liu Bian Li, Eyeful, Dick’s Hard Up, 3 Hard Knights, Full Throttle On Demand, and GoldReallas because they were found to contain undeclared drug ingredients. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 04, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest...

2014-06-02 12:28:29

High Cost and High Expectations for Clinical Benefits are Major Market Access Hurdles Facing New CML Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., June 2, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed hematologists in China estimate that Novartis's Glivec (imatinib) will lose nearly half of its patient share for treatment of chronic myeloid leukemia (CML) in the next three years, due to the market entry of generic imatinib. Nevertheless,...

2014-05-30 12:26:15

Erectile dysfunction is a very common problem and affects tens of millions men over 40 years old in the United States. A local doctor is available to help explain treatment options including the drugs most often prescribed to treat ED such as Cialis, Levitra, and Viagra. JOHNSON CITY, Tenn., May 30, 2014 /PRNewswire-iReach/ -- It is very important to discuss your erectile dysfunction (ED) symptoms and treatment options with experienced medical professionals according to the doctors...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.